Responder Analysis For Fev1 Improvement With Dupilumab In Patients With Persistent Asthma And Elevated Eosinophil Levels

被引：0
|
作者：
Castro, M. [1 ]
Teper, A. [2 ]
Wang, L. [2 ]
Pirozzi, G. [2 ]
Radin, A. [3 ]
Graham, N. [3 ]
Weinstein, S. [3 ]
Wenzel, S. E. [4 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Sanofi, Bridgewater, NJ USA
[3] Regeneron Pharmaceut, Tarrytown, NY USA
[4] Univ Pittsburgh, Asthma Inst, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1321
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Lower Fev1 And Mmef25-75 And Higher Eosinophil Counts Predict Airway Hyperresponsiveness In Patients With Suspected Asthma
    O'Sullivan, J. S.
    Chawke, L. J.
    Fitzgerald, D. B.
    Curran, D. R.
    O'Connor, T. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [32] Blood Eosinophil Counts in Patients with Marked FEV1 Reversibility and Fixed Airflow Obstruction
    Riley, S.
    Al-Lehebi, R.
    Gurupatham, S.
    Grbac, E.
    Stanbrook, M. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [33] Lower FEV1 and MMEF25-75 and Higher Eosinophil Counts Predict Airway Hyperresponsiveness in Patients with Suspected Asthma
    O'Sullivan, J. S.
    Chawke, L. J.
    Fitzgerald, D. B.
    Curran, D. R.
    O'Connor, T. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S524 - S524
  • [34] Exacerbation Reduction In Patients Based Upon Baseline Eosinophil Counts and FEV1 Reversibility
    Yancey, Steven
    Corren, Jonathan
    Price, Robert
    Castro, Mario
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB26 - AB26
  • [35] FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma
    Ansarin, Khalil
    Seiyedrezazadeh, Ensiyeh
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [36] A JOURNEY OF IMPROVEMENT: MEDIAN FEV1 PERCENT PREDICTED FOR PEDIATRIC PATIENTS
    Saeed, M. M.
    Cate, M.
    Salgado-Ho, V. E.
    Saeed, S. H.
    Leong, P.
    Porter, K.
    Chou, T.
    Sohn, E.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S439 - S439
  • [37] BENRALIZUMAB REDUCES EXACERBATIONS FOR PATIENTS WITH OCS-DEPENDENT SEVERE ASTHMA REGARDLESS OF EARLY IMPROVEMENT IN FEV1
    Lugogo, Njira
    Kreindler, James
    Katial, Rohit
    Barker, Peter
    Gil, Esther Garcia
    CHEST, 2020, 158 (04) : 44A - 46A
  • [38] Thoraco-abdominal asynchrony better predicts exercise tolerance than FEV1 in patients with severe persistent asthma
    Prys-Picard, CO
    Niven, RM
    THORAX, 2005, 60 : II50 - II50
  • [39] Longitudinal modeling of prebronchodilator FEV1 response to benralizumab for patients with severe asthma
    Wang, Bing
    Yan, Li
    Yu, Binbing
    Barker, Peter
    Goldman, Mitch
    Roskos, Lorin
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [40] IMPROVED RATE OF DECLINE IN PERCENT PREDICTED FEV1 IS NOT ASSOCIATED WITH ACUTE IMPROVEMENT IN PERCENT PREDICTED FEV1 IN PATIENTS WITH CF TREATED WITH IVACAFTOR
    McKone, E.
    Sawicki, G.
    Millar, S.
    Pasta, D.
    Rubin, J.
    Johnson, C.
    Konstan, M.
    Wagener, J.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 273 - 274
12345